Panel discussion - SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?
28 August 2016 (13:40 - 13:45)
Organised by:
About the speakers
St. Michael's Hospital, Toronto (Canada)
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor D. Fitchett (Toronto, CA)
Professor S. Inzucchi (New Haven, US)
Access the full session
The Event
ESC Congress 2016
28 August 2016
13:40 CET
